Title: | Collective Statement Regarding Patient Access to Approved Therapies from the Center Directors of Parent Project Muscular Dystrophy's Certified Duchenne Care Centers |
Journal : | PLoS Currents, 10 |
Authors: | Ionita C, Author ; Kinnett K ; Mathews K |
Material Type: | Article |
Publication Date: | 2018 |
Languages: | English |
Keywords : | access to health care ; drug marketing regulation in France ; Duchenne muscular dystrophy ; dystrophinopathy ; economy of health ; FDA (Food and drug administration) ; insurance ; medical treatment ; orphan drugs ; prix du médicament ; reimbursement for health expenditure ; United States |
Pubmed / DOI : | DOI : 10.1371/currents.md.4a12c57a46a24603cb3d36d7fe0668b6 / Pubmed : 29623241 |
N° Profil MNM : | 2018042 |
Link for e-copy: | http://www.ncbi.nlm.nih.gov/pubmed/29623241 |